Article citationsMore >>

Mauri, D; et al. Tyrosine Kinase Inhibitors in Treatment of Fibrous Histiocytoma. Experimental Oncology, 209, 31, 1, 60-61.

has been cited by the following article:

Article

Malignant Fibrous Histiocytoma in Lungs: A Case Report

1Department of Surgery, Faculty of Medicine Hasanuddin University, Makassar, Indonesia

2Department of Thoracic and Cardiovascular Surgery, Faculty of Medicine Hasanuddin University, Makassar, Indonesia


American Journal of Medical Case Reports. 2017, Vol. 5 No. 8, 217-220
DOI: 10.12691/ajmcr-5-8-4
Copyright © 2017 Science and Education Publishing

Cite this paper:
Yusfitaria Alvina, Muhammad Nuralim Mallapasi, Rosie Rosie, Prihantono Prihantono. Malignant Fibrous Histiocytoma in Lungs: A Case Report. American Journal of Medical Case Reports. 2017; 5(8):217-220. doi: 10.12691/ajmcr-5-8-4.

Correspondence to: Prihantono  Prihantono, Department of Surgery, Faculty of Medicine Hasanuddin University, Makassar, Indonesia. Email: prihantono.md@gmail.com

Abstract

Malignant Fibrous Histiocytoma (MFH) is a mesenchymal tumor from fibroblast differentiation and histiocyte like cells. This tumor found in 1964 and representing the biggest type of sarcoma. The Incidence of Malignant Fibrous Histiocytoma in lung about 20-24%, with the men and women ratio 2: 1. Diagnosis of Malignant Fibrous Histiocytoma’s hard because found in a patient without symptoms. In this case, a 62 years old patient, professional history as a gold miner for 36 years complained chest pain particularly in the left chest. Investigated by posteroanterior chest radiograph and thoracic CT scan obtained a picture of the left lung tumor, then performed thoracotomy surgery and excision of tumors. Histopathological examination showed a Malignant Fibrous Histiocytoma. Patient is repatriated from the hospital 5 days after surgery in good condition and undergoes routine follow up every six months. Follow up 3 years after Surgery patient is in good health and no sign of residif of the tumor.

Keywords